APA (7th ed.) Citation

Becciolini, A., Psachoulia, E., Biggioggero, M., Crotti, C., Agape, E., Negrini, C., & Favalli, E. (2016). PMS25 - The Introduction of Etanercept Biosimilar In The Practice of A Tertiary Rheumatologic Centre In Italy: A Budget Impact Model. Value in Health, 19(7), A534. https://doi.org/10.1016/j.jval.2016.09.1092

Chicago Style (17th ed.) Citation

Becciolini, A., E. Psachoulia, M. Biggioggero, C. Crotti, E. Agape, C. Negrini, and EG Favalli. "PMS25 - The Introduction of Etanercept Biosimilar In The Practice of A Tertiary Rheumatologic Centre In Italy: A Budget Impact Model." Value in Health 19, no. 7 (2016): A534. https://doi.org/10.1016/j.jval.2016.09.1092.

MLA (9th ed.) Citation

Becciolini, A., et al. "PMS25 - The Introduction of Etanercept Biosimilar In The Practice of A Tertiary Rheumatologic Centre In Italy: A Budget Impact Model." Value in Health, vol. 19, no. 7, 2016, p. A534, https://doi.org/10.1016/j.jval.2016.09.1092.